Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
04/15/2008
Trade Name:
Patanase Nasal Spray
Generic or Proper Name (*):
olopatadine hydrochloride
Indications Studied:
Relief of symptoms of seasonal allergic rhinitis (SAR) in patients 12 years of age and older
Therapeutic Category:
Antihistamine
Ages Studied:
12 years and older
Study #:
3
Study Type:
Safety
Study Design:
Placebo/Parallel Group
No Patients:
72
No Centers:
43
No Countries:
1
BPCA(B), PREA(P):
P
-
-